Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Tumbleweed67on Aug 04, 2010 5:10pm
527 Views
Post# 17322075

RE: Insider sell

RE: Insider sellWhy do you say "ex- Board of Director now"?

Bob Rieder resigned as a director of the Company effective June 24, 2010. The remaining Board members have verbally indicated their intention to remain on the Board until at least the end of 2010.

And yes, have to wonder why he chose to sell now.

TW
Bullboard Posts